NCT03678883 2026-04-039-ING-41 in Patients With Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT03507491 2024-10-04Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid TumorsEmory UniversityPhase 1 Completed24 enrolled
NCT00284752 2012-10-01Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate CancerKaiser PermanentePhase 2 Completed56 enrolled